VistaGen Therapeutics, Inc. (VTGN) Social Stream
VISTAGEN THERAPEUTICS INC (VTGN) Price Targets From Analysts
Use the tables below to see what analysts covering VISTAGEN THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 26 months, VTGN's average price target has gone up $23.25.
VTGN reports an average of 237.5% for its upside potential over the past 32 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VTGN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 25 months, VTGN's average broker recommendation rating worsened by 1.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- VTGN has a higher number of analysts covering the stock than 51.89% of all US stocks.
- VISTAGEN THERAPEUTICS INC's average analyst price target is greater than 56.58% of all US stocks.
- In the context of Pharmaceutical Products stocks, VISTAGEN THERAPEUTICS INC's variance in analysts' estimates is lower than -50.94% of them.
- In the context of stocks in the small market cap category, VISTAGEN THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 148.87% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to VISTAGEN THERAPEUTICS INC are CRMD, MDVL, and SLS.
Is VTGN a Buy, Hold or Sell? See the POWR Ratings now!